Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) - Total Assets

Latest as of March 2026: CN¥2.92 Billion CNY ≈ $426.88 Million USD

Based on the latest financial reports, Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) holds total assets worth CN¥2.92 Billion CNY (≈ $426.88 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 300501 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Total Assets Trend (2011–2025)

This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total assets have evolved over time, based on quarterly financial data. Check Shanghai Haishun New Pharmaceutical Pack (300501) asset resilience to evaluate the company's liquid asset resilience ratio.

Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total assets of CN¥2.92 Billion consist of 43.7% current assets and 56.3% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 11.0%
Accounts Receivable CN¥450.22 Million 15.5%
Inventory CN¥209.89 Million 7.2%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥138.26 Million 4.8%
Goodwill CN¥20.98 Million 0.7%

Asset Composition Trend (2011–2025)

This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shanghai Haishun New Pharmaceutical Pack (300501) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Shanghai Haishun New Pharmaceutical Packaging Co Ltd's current assets represent 43.7% of total assets in 2025, a decrease from 51.1% in 2011.
  • Cash Position: Cash and equivalents constituted 11.0% of total assets in 2025, up from 9.4% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 8.0% in 2011.
  • Asset Diversification: The largest asset category is accounts receivable at 15.5% of total assets.

Shanghai Haishun New Pharmaceutical Packaging Co Ltd Competitors by Total Assets

Key competitors of Shanghai Haishun New Pharmaceutical Packaging Co Ltd based on total assets are shown below.

Company Country Total Assets
Amcor Plc
AU:AMC
Australia AU$37.58 Billion
Shanghai Zijiang Enterprise Group Co Ltd
SHG:600210
China CN¥13.29 Billion
Shantou Wanshun Package Material
SHE:300057
China CN¥11.10 Billion
Huangshan Novel Co Ltd
SHE:002014
China CN¥4.21 Billion
Zhejiang Zhongcheng Packing Material Co Ltd
SHE:002522
China CN¥3.54 Billion
Irani Papel e Embalagem S.A
SA:RANI3
Brazil R$4.14 Billion
Orora Ltd
AU:ORA
Australia AU$4.85 Billion
Pact Group Holdings Ltd
AU:PGH
Australia AU$2.05 Billion

Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.66 2.67 1.26
Quick Ratio 2.18 2.15 0.95
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥815.03 Million CN¥770.82 Million CN¥123.95 Million

Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Advanced Valuation Insights

This section examines the relationship between Shanghai Haishun New Pharmaceutical Packaging Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.56
Latest Market Cap to Assets Ratio 0.20
Asset Growth Rate (YoY) 0.7%
Total Assets CN¥2.91 Billion
Market Capitalization $570.71 Million USD

Valuation Analysis

Below Book Valuation: The market values Shanghai Haishun New Pharmaceutical Packaging Co Ltd's assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Shanghai Haishun New Pharmaceutical Packaging Co Ltd's assets grew by 0.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2025)

The table below shows the annual total assets of Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2025.

Year Total Assets Change
2025-12-31 CN¥2.91 Billion
≈ $425.37 Million
+0.74%
2024-12-31 CN¥2.89 Billion
≈ $422.27 Million
-3.38%
2023-12-31 CN¥2.99 Billion
≈ $437.03 Million
+29.55%
2022-12-31 CN¥2.31 Billion
≈ $337.35 Million
+1.82%
2021-12-31 CN¥2.26 Billion
≈ $331.30 Million
+61.09%
2020-12-31 CN¥1.41 Billion
≈ $205.67 Million
+13.82%
2019-12-31 CN¥1.23 Billion
≈ $180.70 Million
+31.02%
2018-12-31 CN¥942.48 Million
≈ $137.91 Million
+32.77%
2017-12-31 CN¥709.87 Million
≈ $103.88 Million
+3.80%
2016-12-31 CN¥683.89 Million
≈ $100.08 Million
+101.84%
2015-12-31 CN¥338.83 Million
≈ $49.58 Million
+17.63%
2014-12-31 CN¥288.04 Million
≈ $42.15 Million
+12.04%
2013-12-31 CN¥257.08 Million
≈ $37.62 Million
+16.68%
2012-12-31 CN¥220.32 Million
≈ $32.24 Million
+17.70%
2011-12-31 CN¥187.19 Million
≈ $27.39 Million
--

About Shanghai Haishun New Pharmaceutical Packaging Co Ltd

SHE:300501 China Packaging & Containers
Market Cap
$570.71 Million
CN¥3.90 Billion CNY
Market Cap Rank
#11827 Global
#3499 in China
Share Price
CN¥14.02
Change (1 day)
+1.45%
52-Week Range
CN¥13.50 - CN¥21.10
All Time High
CN¥46.87
About

HySum Flexibles Global, Inc. engages in the manufacture, sale, and export of pharmaceutical packaging products in China and internationally. The company offers pharmaceutical packaging products, including cold-form, tropical blister foil, PVC/Aclar sheets, PTP lidding, hipack child-resistant packaging, hipack AL/PE strip packs, hipack complex laminated flexible films, lamination foil and pouch, c… Read more